nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—ADRA1B—vas deferens—urinary bladder cancer	0.218	0.424	CbGeAlD
Phentolamine—NISCH—Podofilox—Etoposide—urinary bladder cancer	0.0237	1	CbGdCrCtD
Phentolamine—NISCH—prostate gland—urinary bladder cancer	0.0228	0.0444	CbGeAlD
Phentolamine—ADRA1D—prostate gland—urinary bladder cancer	0.0191	0.037	CbGeAlD
Phentolamine—NISCH—smooth muscle tissue—urinary bladder cancer	0.0162	0.0314	CbGeAlD
Phentolamine—NISCH—urethra—urinary bladder cancer	0.0153	0.0297	CbGeAlD
Phentolamine—Injection site reaction—Mitomycin—urinary bladder cancer	0.0147	0.0319	CcSEcCtD
Phentolamine—ADRA1D—epithelium—urinary bladder cancer	0.014	0.0272	CbGeAlD
Phentolamine—SIGMAR1—prostate gland—urinary bladder cancer	0.0133	0.0258	CbGeAlD
Phentolamine—ADRA1B—renal system—urinary bladder cancer	0.0133	0.0258	CbGeAlD
Phentolamine—ADRA1D—urethra—urinary bladder cancer	0.0128	0.0248	CbGeAlD
Phentolamine—Oral pain—Epirubicin—urinary bladder cancer	0.0115	0.0249	CcSEcCtD
Phentolamine—NISCH—vagina—urinary bladder cancer	0.0113	0.0219	CbGeAlD
Phentolamine—SIGMAR1—seminal vesicle—urinary bladder cancer	0.0112	0.0218	CbGeAlD
Phentolamine—ADRA1A—prostate gland—urinary bladder cancer	0.0109	0.0213	CbGeAlD
Phentolamine—Oral pain—Doxorubicin—urinary bladder cancer	0.0106	0.023	CcSEcCtD
Phentolamine—ADRA2C—prostate gland—urinary bladder cancer	0.0104	0.0203	CbGeAlD
Phentolamine—ADRA1D—female reproductive system—urinary bladder cancer	0.0104	0.0202	CbGeAlD
Phentolamine—SIGMAR1—smooth muscle tissue—urinary bladder cancer	0.0094	0.0183	CbGeAlD
Phentolamine—Injection site pain—Thiotepa—urinary bladder cancer	0.00912	0.0198	CcSEcCtD
Phentolamine—SIGMAR1—urethra—urinary bladder cancer	0.00889	0.0173	CbGeAlD
Phentolamine—ADRA2C—seminal vesicle—urinary bladder cancer	0.00882	0.0171	CbGeAlD
Phentolamine—ADRA2A—prostate gland—urinary bladder cancer	0.00832	0.0162	CbGeAlD
Phentolamine—ADRA1A—epithelium—urinary bladder cancer	0.00804	0.0156	CbGeAlD
Phentolamine—Chest pain—Valrubicin—urinary bladder cancer	0.008	0.0173	CcSEcCtD
Phentolamine—ADRA1A—renal system—urinary bladder cancer	0.00746	0.0145	CbGeAlD
Phentolamine—NISCH—lymph node—urinary bladder cancer	0.00729	0.0142	CbGeAlD
Phentolamine—Tenderness—Gemcitabine—urinary bladder cancer	0.00718	0.0156	CcSEcCtD
Phentolamine—ADRA2C—renal system—urinary bladder cancer	0.00711	0.0138	CbGeAlD
Phentolamine—Tenderness—Fluorouracil—urinary bladder cancer	0.00706	0.0153	CcSEcCtD
Phentolamine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00704	0.0137	CbGeAlD
Phentolamine—ADRA2C—urethra—urinary bladder cancer	0.00698	0.0136	CbGeAlD
Phentolamine—Tenderness—Cisplatin—urinary bladder cancer	0.00669	0.0145	CcSEcCtD
Phentolamine—SIGMAR1—vagina—urinary bladder cancer	0.00656	0.0127	CbGeAlD
Phentolamine—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00627	0.0136	CcSEcCtD
Phentolamine—Injection site reaction—Gemcitabine—urinary bladder cancer	0.00623	0.0135	CcSEcCtD
Phentolamine—Pain—Carboplatin—urinary bladder cancer	0.00607	0.0132	CcSEcCtD
Phentolamine—Abdominal pain—Valrubicin—urinary bladder cancer	0.00606	0.0131	CcSEcCtD
Phentolamine—Hypertension—Mitomycin—urinary bladder cancer	0.00559	0.0121	CcSEcCtD
Phentolamine—ADRA2A—urethra—urinary bladder cancer	0.00557	0.0108	CbGeAlD
Phentolamine—Asthenia—Valrubicin—urinary bladder cancer	0.0055	0.0119	CcSEcCtD
Phentolamine—Pruritus—Valrubicin—urinary bladder cancer	0.00543	0.0118	CcSEcCtD
Phentolamine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00525	0.0114	CcSEcCtD
Phentolamine—ADRA2C—vagina—urinary bladder cancer	0.00515	0.01	CbGeAlD
Phentolamine—Dizziness—Valrubicin—urinary bladder cancer	0.00507	0.011	CcSEcCtD
Phentolamine—Vomiting—Valrubicin—urinary bladder cancer	0.00488	0.0106	CcSEcCtD
Phentolamine—Headache—Valrubicin—urinary bladder cancer	0.0048	0.0104	CcSEcCtD
Phentolamine—Nasal congestion—Cisplatin—urinary bladder cancer	0.00465	0.0101	CcSEcCtD
Phentolamine—Nausea—Valrubicin—urinary bladder cancer	0.00456	0.00987	CcSEcCtD
Phentolamine—ADRA2A—female reproductive system—urinary bladder cancer	0.00454	0.00883	CbGeAlD
Phentolamine—Pain—Mitomycin—urinary bladder cancer	0.00452	0.00979	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—urinary bladder cancer	0.00424	0.00824	CbGeAlD
Phentolamine—ADRA2A—vagina—urinary bladder cancer	0.00411	0.00798	CbGeAlD
Phentolamine—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00387	0.00839	CcSEcCtD
Phentolamine—Asthenia—Mitomycin—urinary bladder cancer	0.00379	0.00821	CcSEcCtD
Phentolamine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.00376	0.00815	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—urinary bladder cancer	0.00367	0.00796	CcSEcCtD
Phentolamine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00362	0.00783	CcSEcCtD
Phentolamine—Dizziness—Mitomycin—urinary bladder cancer	0.00349	0.00757	CcSEcCtD
Phentolamine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00347	0.00752	CcSEcCtD
Phentolamine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.00345	0.00748	CcSEcCtD
Phentolamine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.00344	0.00744	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—urinary bladder cancer	0.0034	0.00736	CcSEcCtD
Phentolamine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.0034	0.00736	CcSEcCtD
Phentolamine—Angiopathy—Thiotepa—urinary bladder cancer	0.00339	0.00735	CcSEcCtD
Phentolamine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00338	0.00732	CcSEcCtD
Phentolamine—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00337	0.0073	CcSEcCtD
Phentolamine—Vomiting—Mitomycin—urinary bladder cancer	0.00336	0.00728	CcSEcCtD
Phentolamine—Arrhythmia—Thiotepa—urinary bladder cancer	0.00334	0.00724	CcSEcCtD
Phentolamine—ADRA2C—lymph node—urinary bladder cancer	0.00333	0.00647	CbGeAlD
Phentolamine—Headache—Mitomycin—urinary bladder cancer	0.00331	0.00717	CcSEcCtD
Phentolamine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.00322	0.00697	CcSEcCtD
Phentolamine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.0032	0.00694	CcSEcCtD
Phentolamine—Nausea—Mitomycin—urinary bladder cancer	0.00314	0.0068	CcSEcCtD
Phentolamine—Bradycardia—Cisplatin—urinary bladder cancer	0.00299	0.00647	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—urinary bladder cancer	0.00298	0.00646	CcSEcCtD
Phentolamine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00295	0.00639	CcSEcCtD
Phentolamine—Myocardial infarction—Etoposide—urinary bladder cancer	0.00293	0.00635	CcSEcCtD
Phentolamine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00292	0.00632	CcSEcCtD
Phentolamine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00285	0.00618	CcSEcCtD
Phentolamine—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00284	0.00614	CcSEcCtD
Phentolamine—Hypertension—Thiotepa—urinary bladder cancer	0.00281	0.00609	CcSEcCtD
Phentolamine—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00281	0.00609	CcSEcCtD
Phentolamine—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00276	0.00599	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—urinary bladder cancer	0.00276	0.00597	CcSEcCtD
Phentolamine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00272	0.00589	CcSEcCtD
Phentolamine—Flushing—Cisplatin—urinary bladder cancer	0.00272	0.00589	CcSEcCtD
Phentolamine—ADRA2A—lymph node—urinary bladder cancer	0.00266	0.00516	CbGeAlD
Phentolamine—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00264	0.00572	CcSEcCtD
Phentolamine—Arrhythmia—Cisplatin—urinary bladder cancer	0.00262	0.00567	CcSEcCtD
Phentolamine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00261	0.00564	CcSEcCtD
Phentolamine—Tachycardia—Thiotepa—urinary bladder cancer	0.00259	0.00562	CcSEcCtD
Phentolamine—Cardiac disorder—Etoposide—urinary bladder cancer	0.00249	0.0054	CcSEcCtD
Phentolamine—Flushing—Etoposide—urinary bladder cancer	0.00249	0.0054	CcSEcCtD
Phentolamine—Angiopathy—Etoposide—urinary bladder cancer	0.00244	0.00528	CcSEcCtD
Phentolamine—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00242	0.00524	CcSEcCtD
Phentolamine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00239	0.00517	CcSEcCtD
Phentolamine—Hypertension—Gemcitabine—urinary bladder cancer	0.00236	0.00512	CcSEcCtD
Phentolamine—Chest pain—Gemcitabine—urinary bladder cancer	0.00233	0.00505	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00229	0.00497	CcSEcCtD
Phentolamine—Chest pain—Fluorouracil—urinary bladder cancer	0.00229	0.00497	CcSEcCtD
Phentolamine—Pain—Thiotepa—urinary bladder cancer	0.00227	0.00492	CcSEcCtD
Phentolamine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00219	0.00475	CcSEcCtD
Phentolamine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00217	0.00471	CcSEcCtD
Phentolamine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00216	0.00467	CcSEcCtD
Phentolamine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00214	0.00465	CcSEcCtD
Phentolamine—Abdominal pain—Thiotepa—urinary bladder cancer	0.0021	0.00455	CcSEcCtD
Phentolamine—Hypotension—Gemcitabine—urinary bladder cancer	0.00209	0.00452	CcSEcCtD
Phentolamine—Hypotension—Fluorouracil—urinary bladder cancer	0.00205	0.00445	CcSEcCtD
Phentolamine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00204	0.00443	CcSEcCtD
Phentolamine—Tachycardia—Cisplatin—urinary bladder cancer	0.00203	0.0044	CcSEcCtD
Phentolamine—Hypertension—Etoposide—urinary bladder cancer	0.00202	0.00437	CcSEcCtD
Phentolamine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00201	0.00435	CcSEcCtD
Phentolamine—Chest pain—Etoposide—urinary bladder cancer	0.00199	0.00431	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00199	0.00431	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.00199	0.00431	CcSEcCtD
Phentolamine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00197	0.00427	CcSEcCtD
Phentolamine—Hypotension—Cisplatin—urinary bladder cancer	0.00195	0.00422	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00193	0.00418	CcSEcCtD
Phentolamine—Pain—Gemcitabine—urinary bladder cancer	0.00191	0.00414	CcSEcCtD
Phentolamine—Asthenia—Thiotepa—urinary bladder cancer	0.00191	0.00413	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.0019	0.00411	CcSEcCtD
Phentolamine—Pruritus—Thiotepa—urinary bladder cancer	0.00188	0.00407	CcSEcCtD
Phentolamine—Pain—Fluorouracil—urinary bladder cancer	0.00188	0.00407	CcSEcCtD
Phentolamine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00187	0.00405	CcSEcCtD
Phentolamine—Tachycardia—Etoposide—urinary bladder cancer	0.00186	0.00403	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00184	0.00398	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.00184	0.00398	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—urinary bladder cancer	0.00183	0.00397	CcSEcCtD
Phentolamine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00182	0.00394	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.0018	0.0039	CcSEcCtD
Phentolamine—Hypotension—Etoposide—urinary bladder cancer	0.00178	0.00386	CcSEcCtD
Phentolamine—Pain—Cisplatin—urinary bladder cancer	0.00178	0.00386	CcSEcCtD
Phentolamine—Dizziness—Thiotepa—urinary bladder cancer	0.00176	0.00381	CcSEcCtD
Phentolamine—Paraesthesia—Etoposide—urinary bladder cancer	0.00171	0.00371	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.0017	0.00367	CcSEcCtD
Phentolamine—Vomiting—Thiotepa—urinary bladder cancer	0.00169	0.00366	CcSEcCtD
Phentolamine—Headache—Thiotepa—urinary bladder cancer	0.00166	0.00361	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00165	0.00357	CcSEcCtD
Phentolamine—Pain—Etoposide—urinary bladder cancer	0.00163	0.00354	CcSEcCtD
Phentolamine—Asthenia—Gemcitabine—urinary bladder cancer	0.0016	0.00347	CcSEcCtD
Phentolamine—Pruritus—Gemcitabine—urinary bladder cancer	0.00158	0.00343	CcSEcCtD
Phentolamine—Nausea—Thiotepa—urinary bladder cancer	0.00158	0.00342	CcSEcCtD
Phentolamine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00156	0.00338	CcSEcCtD
Phentolamine—Pruritus—Fluorouracil—urinary bladder cancer	0.00155	0.00337	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—urinary bladder cancer	0.00153	0.00332	CcSEcCtD
Phentolamine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00153	0.00331	CcSEcCtD
Phentolamine—Abdominal pain—Etoposide—urinary bladder cancer	0.00151	0.00327	CcSEcCtD
Phentolamine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0015	0.00326	CcSEcCtD
Phentolamine—Asthenia—Cisplatin—urinary bladder cancer	0.00149	0.00324	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00149	0.00323	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—urinary bladder cancer	0.00146	0.00316	CcSEcCtD
Phentolamine—Dizziness—Fluorouracil—urinary bladder cancer	0.00145	0.00315	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00145	0.00314	CcSEcCtD
Phentolamine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00143	0.00309	CcSEcCtD
Phentolamine—Vomiting—Gemcitabine—urinary bladder cancer	0.00142	0.00308	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—urinary bladder cancer	0.00142	0.00307	CcSEcCtD
Phentolamine—Headache—Gemcitabine—urinary bladder cancer	0.0014	0.00303	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.0014	0.00303	CcSEcCtD
Phentolamine—Flushing—Epirubicin—urinary bladder cancer	0.0014	0.00303	CcSEcCtD
Phentolamine—Vomiting—Fluorouracil—urinary bladder cancer	0.0014	0.00303	CcSEcCtD
Phentolamine—Headache—Fluorouracil—urinary bladder cancer	0.00138	0.00298	CcSEcCtD
Phentolamine—Asthenia—Etoposide—urinary bladder cancer	0.00137	0.00297	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—urinary bladder cancer	0.00137	0.00296	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00136	0.00294	CcSEcCtD
Phentolamine—Pruritus—Etoposide—urinary bladder cancer	0.00135	0.00292	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—urinary bladder cancer	0.00135	0.00291	CcSEcCtD
Phentolamine—Nausea—Gemcitabine—urinary bladder cancer	0.00133	0.00288	CcSEcCtD
Phentolamine—Vomiting—Cisplatin—urinary bladder cancer	0.00132	0.00287	CcSEcCtD
Phentolamine—Diarrhoea—Etoposide—urinary bladder cancer	0.00131	0.00283	CcSEcCtD
Phentolamine—Nausea—Fluorouracil—urinary bladder cancer	0.00131	0.00283	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00129	0.0028	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—urinary bladder cancer	0.00129	0.0028	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—urinary bladder cancer	0.00126	0.00274	CcSEcCtD
Phentolamine—Dizziness—Etoposide—urinary bladder cancer	0.00126	0.00273	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00126	0.00272	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00124	0.0027	CcSEcCtD
Phentolamine—Nausea—Cisplatin—urinary bladder cancer	0.00124	0.00268	CcSEcCtD
Phentolamine—Vomiting—Etoposide—urinary bladder cancer	0.00121	0.00263	CcSEcCtD
Phentolamine—Headache—Etoposide—urinary bladder cancer	0.0012	0.00259	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—urinary bladder cancer	0.00119	0.00258	CcSEcCtD
Phentolamine—Nausea—Etoposide—urinary bladder cancer	0.00113	0.00246	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—urinary bladder cancer	0.00113	0.00245	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00112	0.00243	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—urinary bladder cancer	0.00112	0.00242	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—urinary bladder cancer	0.00107	0.00231	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00105	0.00227	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—urinary bladder cancer	0.00105	0.00227	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—urinary bladder cancer	0.00104	0.00226	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—urinary bladder cancer	0.00103	0.00224	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—urinary bladder cancer	0.00103	0.00222	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—urinary bladder cancer	0.001	0.00217	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000987	0.00214	CcSEcCtD
Phentolamine—Pain—Methotrexate—urinary bladder cancer	0.000978	0.00212	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000971	0.0021	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000966	0.00209	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000961	0.00208	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000935	0.00202	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—urinary bladder cancer	0.000925	0.002	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000924	0.002	CcSEcCtD
Phentolamine—Pain—Epirubicin—urinary bladder cancer	0.000915	0.00198	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000904	0.00196	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000889	0.00193	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000875	0.00189	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000855	0.00185	CcSEcCtD
Phentolamine—Pain—Doxorubicin—urinary bladder cancer	0.000847	0.00183	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000846	0.00183	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—urinary bladder cancer	0.00082	0.00178	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00081	0.00175	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—urinary bladder cancer	0.000809	0.00175	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000783	0.0017	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000782	0.00169	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—urinary bladder cancer	0.000768	0.00166	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—urinary bladder cancer	0.000757	0.00164	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—urinary bladder cancer	0.000756	0.00164	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000732	0.00159	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—urinary bladder cancer	0.000727	0.00157	CcSEcCtD
Phentolamine—Headache—Methotrexate—urinary bladder cancer	0.000716	0.00155	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—urinary bladder cancer	0.00071	0.00154	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—urinary bladder cancer	0.000708	0.00153	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—urinary bladder cancer	0.0007	0.00152	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—urinary bladder cancer	0.00068	0.00147	CcSEcCtD
Phentolamine—Nausea—Methotrexate—urinary bladder cancer	0.000679	0.00147	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000677	0.00147	CcSEcCtD
Phentolamine—Headache—Epirubicin—urinary bladder cancer	0.00067	0.00145	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—urinary bladder cancer	0.000655	0.00142	CcSEcCtD
Phentolamine—Nausea—Epirubicin—urinary bladder cancer	0.000636	0.00138	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—urinary bladder cancer	0.000629	0.00136	CcSEcCtD
Phentolamine—Headache—Doxorubicin—urinary bladder cancer	0.00062	0.00134	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—urinary bladder cancer	0.000588	0.00127	CcSEcCtD
